| 1 |
Siegel RL， Miller KD， Jemal A. Cancer statistics， 2020 ［J］. CA Cancer J Clin， 2020， 70（1）: 7-30.
|
| 2 |
李越， 周祺祺， 赵洪猛. 初诊Ⅳ期乳腺癌的外科治疗进展 ［J/OL］.中华临床医师杂志（电子版）， 2023， 17（10）: 1097-1101.
|
| 3 |
Miller KD， Nogueira L， Mariotto AB， et al. Cancer treatment and survivorship statistics， 2019 ［J］. CA Cancer J Clin， 2019， 69（5）:363-85.
|
| 4 |
Terry MB， Colditz GA. Epidemiology and risk factors for breast cancer: 21st century advances， gaps to address through interdisciplinary science ［J］. Cold Spring Harb Perspect Med， 2023，13（9）: a041317.
|
| 5 |
Smith GD， Ebrahim S. Data dredging， bias， or confounding ［J］. Bmj，2002， 325（7378）: 1437-1438.
|
| 6 |
Katan MB. Apolipoprotein E isoforms， serum cholesterol， and cancer［J］. Lancet， 1986， 1（8479）: 507-508.
|
| 7 |
Thomas DC， Conti DV. Commentary: the concept of ‘Mendelian Randomization’ ［J］. Int J Epidemiol， 2004， 33（1）: 21-25.
|
| 8 |
Skrivankova VW， Richmond RC， Woolf BAR， et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: The STROBE-MR Statement ［J］. Jama， 2021， 326（16）:1614-1621.
|
| 9 |
Hingorani A， Humphries S. Nature’s randomised trials ［J］. Lancet，2005， 366（9501）: 1906-1908.
|
| 10 |
Sekula P， Del Greco MF， Pattaro C， et al. Mendelian randomization as an approach to assess causality using observational data ［J］. J Am Soc Nephrol， 2016， 27（11）: 3253-3265.
|
| 11 |
王莉娜， Zuofeng Z. 孟德尔随机化法在因果推断中的应用 ［J］. 中华流行病学杂志， 2017， 38（4）: 547-552.
|
| 12 |
Emdin CA， Khera AV， Kathiresan S. Mendelian randomization ［J］.JAMA， 2017， 318（19）: 1925-1926.
|
| 13 |
Burgess S， Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies ［J］. Int J Epidemiol， 2011， 40（3）:755-764.
|
| 14 |
Burgess S， Butterworth A， Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data ［J］.Genet Epidemiol， 2013， 37（7）: 658-665.
|
| 15 |
Burgess S， Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method ［J］. Eur J Epidemiol， 2017，32（5）: 377-389.
|
| 16 |
Bowden J， Davey Smith G， Haycock PC， et al. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator ［J］. Genet Epidemiol， 2016， 40（4）: 304-314.
|
| 17 |
Verbanck M， Chen CY， Neale B， et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases ［J］. Nat Genet，2018， 50（5）: 693-698.
|
| 18 |
Greco MF， Minelli C， Sheehan NA， et al. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome ［J］. Stat Med， 2015， 34（21）: 2926-2940.
|
| 19 |
Pierce SE， Booms A， Prahl J， et al. Post-GWAS knowledge gap: the how， where， and when ［J］. NPJ Parkinsons Dis， 2020， 6: 23.
|
| 20 |
王玉琢， 沈洪兵. 孟德尔随机化研究应用于因果推断的影响因素及其结果解读面临的挑战 ［J］. 中华流行病学杂志， 2020， 41（8）: 1231-1236.
|
| 21 |
Key T， Appleby P， Barnes I， et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies ［J］. J Natl Cancer Inst， 2002， 94（8）: 606-616.
|
| 22 |
Key TJ， Appleby PN， Reeves GK， et al. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies ［J］. Lancet Oncol， 2013， 14（10）: 1009-1019.
|
| 23 |
Bhaskaran K， Douglas I， Forbes H， et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults ［J］. Lancet， 2014， 384（9945）: 755-765.
|
| 24 |
Mccormack VA， Dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis ［J］. Cancer Epidemiol Biomarkers Prev， 2006， 15（6）: 1159-1169.
|
| 25 |
Boyd NF， Guo H， Martin LJ， et al. Mammographic density and the risk and detection of breast cancer ［J］. N Engl J Med， 2007， 356（3）: 227-236.
|
| 26 |
Nounu A， Kar SP， Relton CL， et al. Sex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study ［J］. Breast Cancer Res， 2022， 24（1）: 66.
|
| 27 |
Larsson SC， Kar S， Perry JRB， et al. Serum Estradiol and 20 Site-Specific Cancers in Women: Mendelian Randomization Study ［J］. J Clin Endocrinol Metab， 2022， 107（2）: e467-e474.
|
| 28 |
Ke B， Li C， Shang H. Sex hormones in the risk of breast cancer: a twosample Mendelian randomization study ［J］. Am J Cancer Res， 2023，13（3）: 1128-1136.
|
| 29 |
Schoemaker MJ， Nichols HB， Wright LB， et al. Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women ［J］. JAMA Oncol， 2018， 4（11）: e181771.
|
| 30 |
Ooi BNS， Loh H， Ho PJ， et al. The genetic interplay between body mass index， breast size and breast cancer risk: a Mendelian randomization analysis ［J］. Int J Epidemiol， 2019， 48（3）: 781-794.
|
| 31 |
Guo Y， Warren Andersen S， Shu XO， et al. Genetically predicted body mass index and breast cancer risk: mendelian randomization analyses of data from 145，000 women of European descent ［J］. PLoS Med，2016， 13（8）: e1002105.
|
| 32 |
Gao C， Patel CJ， Michailidou K， et al. Mendelian randomization study of adiposity-related traits and risk of breast， ovarian， prostate， lung and colorectal cancer ［J］. Int J Epidemiol， 2016， 45（3）: 896-908.
|
| 33 |
Shu X， Wu L， Khankari NK， et al. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis ［J］. Int J Epidemiol， 2019， 48（3）: 795-806.
|
| 34 |
Fang X， Wang X， Song Z， et al. Causal association of childhood obesity with cancer risk in adulthood: A Mendelian randomization study ［J］. Int J Cancer， 2021， 149（7）: 1421-1425.
|
| 35 |
Hao Y， Xiao J， Liang Y， et al. Reassessing the causal role of obesity in breast cancer susceptibility: a comprehensive multivariable Mendelian randomization investigating the distribution and timing of exposure ［J］.Int J Epidemiol， 2023， 52（1）: 58-70.
|
| 36 |
Pettersson A， Graff RE， Ursin G， et al. Mammographic density phenotypes and risk of breast cancer: a meta-analysis ［J］. J Natl Cancer Inst， 2014， 106（5）: dju078.
|
| 37 |
Sieh W， Rothstein JH， Klein R J， et al. Identification of 31 loci for mammographic density phenotypes and their associations with breast cancer risk ［J］. Nat Commun， 2020， 11（1）: 5116.
|
| 38 |
Key TJ， Bradbury KE， Perez-cornago A， et al. Diet， nutrition， and cancer risk: what do we know and what is the way forward? ［J］. Bmj，2020， 368: m511.
|
| 39 |
Ellingjord-Dale M， Papadimitriou N， Katsoulis M， et al. Coffee consumption and risk of breast cancer: A Mendelian randomization study ［J］. PLoS One， 2021， 16（1）: e0236904.
|
| 40 |
Deng Y， Ge W， Xu H， et al. A Mendelian randomization study of the effect of tea intake on breast cancer ［J］. Front Nutr， 2022， 9: 956969.
|
| 41 |
Wang X， Chen L， Cao R， et al. Associations of 10 dietary habits with breast cancer: a Mendelian randomization study ［J］. Front Nutr， 2023，10: 1215220.
|
| 42 |
Jin C， Li R， Deng T， et al. Association between dried fruit intake and pan-cancers incidence risk: A two-sample Mendelian randomization study ［J］. Front Nutr， 2022， 9: 899137.
|
| 43 |
Wu S， Ma X， Zhang X， et al. Relationship between oily fish intake and breast cancer based on estrogen receptor status: a Mendelian randomization study ［J］. Breast Cancer Res Treat， 2024， 203（1）: 145-152.
|
| 44 |
Dong H， Kong X， Wang X， et al. The causal effect of dietary composition on the risk of breast cancer: A mendelian randomization study ［J］. Nutrients， 2023， 15（11）: 2586.
|
| 45 |
Zhao H， Wu S， Liu H， et al. Relationship between food-derived antioxidant vitamin intake and breast cancer risk: a mendelian randomized study ［J］. Eur J Nutr， 2023， 62（6）: 2365-2373.
|
| 46 |
Zhong S， Zhang X， Chen L， et al. Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies［J］. Cancer Treat Rev， 2015， 41（6）: 554-567.
|
| 47 |
Nowak C， Ärnlöv J. A Mendelian randomization study of the effects of blood lipids on breast cancer risk ［J］. Nat Commun， 2018， 9（1）: 3957.
|
| 48 |
Johnson KE， Siewert KM， Klarin D， et al. The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study ［J］. PLoS Med， 2020， 17（9）: e1003302.
|
| 49 |
Beeghly-Fadiel A， Khankari NK， Delahanty RJ， et al. A Mendelian randomization analysis of circulating lipid traits and breast cancer risk［J］. Int J Epidemiol， 2020， 49（4）: 1117-1131.
|
| 50 |
Wang Y， Liu F， Sun L， et al. Association between human blood metabolome and the risk of breast cancer ［J］. Breast Cancer Res， 2023，25（1）: 9.
|
| 51 |
Tang SN， Zuber V， Tsilidis KK. Identifying and ranking causal biochemical biomarkers for breast cancer: a Mendelian randomisation study ［J］. BMC Med， 2022， 20（1）: 457.
|
| 52 |
Zhou M， Henricks M， Loch V， et al. Mendelian randomization analysis revealed potential metabolic causal factors for breast cancer ［J］. Sci Rep， 2023， 13（1）: 14290.
|
| 53 |
Marchesi JR， Adams DH， Fava F， et al. The gut microbiota and host health: a new clinical frontier ［J］. Gut， 2016， 65（2）: 330-339.
|
| 54 |
Sommer F， Bäckhed F. The gut microbiota--masters of host development and physiology ［J］. Nat Rev Microbiol， 2013， 11（4）: 227-238.
|
| 55 |
Goedert JJ， Jones G， Hua X， et al. Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study ［J］. J Natl Cancer Inst， 2015， 107（8）: djv147.
|
| 56 |
Zhang S， Zhang W， Ren H， et al. Mendelian randomization analysis revealed a gut microbiota-mammary axis in breast cancer ［J］. Front Microbiol， 2023， 14: 1193725.
|
| 57 |
Joseph KR， Edirimanne S， Eslick GD. The association between breast cancer and thyroid cancer: a meta-analysis ［J］. Breast Cancer Res Treat， 2015， 152（1）: 173-181.
|
| 58 |
Nielsen SM， White MG， Hong S， et al. The breast-thyroid cancer link: A systematic review and meta-analysis ［J］. Cancer Epidemiol Biomarkers Prev， 2016， 25（2）: 231-238.
|
| 59 |
Muller I， Barrett-Lee PJ. The antigenic link between thyroid autoimmunity and breast cancer ［J］. Semin Cancer Biol， 2020， 64:122-134.
|
| 60 |
Halada S， Casado-Medrano V， Baran JA， et al. Hormonal crosstalk between thyroid and breast cancer ［J］. Endocrinology， 2022， 163（7）:bqac075.
|
| 61 |
Piek MW， De Boer JP， Van Duijnhoven F， et al. The co-occurrence of both breast- and differentiated thyroid cancer: incidence， association and clinical implications for daily practice ［J］. BMC Cancer， 2022，22（1）: 1018.
|
| 62 |
Liu J， Liang L. The association between thyroid and breast cancers:a bidirectional mendelian randomization study ［J］. Front Endocrinol（Lausanne）， 2023， 14: 1185497.
|